NT3 Gene
Introduction
Nt3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@maisonpierre1990]
title: NT3 Gene [@tessarollo1994]
--- [@lamballe1994]
<div class="infobox .infobox-gene"> [@lyons1999]
<table> [@murer2001]
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.1em;">NTF3 (Neurotrophin 3)</th></tr> [@zhang2009]
<tr><td><b>Full Name</b></td><td>Neurotrophin 3</td></tr> [@nagahara2009]
<tr><td><b>Chromosomal Location</b></td><td>12p13.31</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>[4900](https://www.ncbi.nlm.nih.gov/gene/4900)</td></tr>
<tr><td><b>OMIM</b></td><td>[162660](https://www.omim.org/entry/162660)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000185652](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185652)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P20783](https://www.uniprot.org/uniprot/P20783)</td></tr>
<tr><td><b>Protein Class</b></td><td>Neurotrophic factor</td></tr>
<tr><td><b>Primary Receptor</b></td><td>TrkC (TyrKc)</td></tr>
<tr><td><b>Gene Family</b></td><td>Neurotrophin</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">23 edges</a></td>
</tr>
</table>
</div>
Overview
Mermaid diagram (expand to render)
Neurotrophin-3 (NT-3), encoded by the NTF3 gene, is a member of the neurotrophin family of growth factors that also includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophin-4 (NT-4). NT-3 promotes the survival, differentiation, and functional maintenance of neuronal populations during development and throughout life. Unlike other neurotrophins, NT-3 has a broader receptor repertoire, binding with highest affinity to TrkC but also activating TrkB and TrkA with lower affinity.
Molecular Mechanisms
Receptor Binding and Signaling
NT-3 binds to the TrkC receptor (tropomyosin receptor kinase C), a receptor tyrosine kinase, with high affinity (Kd ~10⁻¹¹ M). Binding induces receptor dimerization and autophosphorylation, activating three major downstream signaling cascades:
PI3K/Akt Pathway: Phosphatidylinositol 3-kinase (PI3K) activation leads to Akt phosphorylation, promoting neuronal survival through phosphorylation of BAD and activation of [mTOR](/entities/mtor) signaling.
MAPK/ERK Pathway: Ras/Raf/MEK/ERK cascade activation promotes neuronal differentiation, dendritic growth, and synaptic plasticity through transcription factor activation (CREB, Elk-1).
PLCγ Pathway: Phospholipase C-gamma (PLCγ) activation increases intracellular Ca²⁺ and activates PKC, modulating synaptic transmission and plasticity.Precursor Processing
NT-3 is synthesized as a pre-proprotein (pre-pro-NT3), with the preprodomain directing secretion via the secretory pathway. The mature NT-3 protein (119 amino acids) forms a homodimer that is secreted and can bind to both p75NTR (pan-neurotrophin receptor) and Trk receptors. The p75NTR binding can either enhance or inhibit Trk signaling depending on cellular context.
Normal Function
Nervous System Development
During embryonic development, NT-3 is critical for:
- Proprioceptive sensory neuron development and survival
- Sympathetic neuron differentiation
- Cholinergic neuron development in the basal forebrain
- GABAergic neuron maturation in the [cortex](/brain-regions/cortex)
- Axonal guidance via chemotropic effects
Adult Nervous System
In the adult brain, NT-3 maintains:
- Synaptic plasticity in the hippocampus and cortex
- Neuronal survival in the basal forebrain cholinergic system
- Sensory neuron function in peripheral nervous system
- Cognitive function particularly in memory and learning
Disease Associations
Alzheimer's Disease
NT-3 levels are reduced in AD brains, particularly in the hippocampus and cortex. NT-3 deficiency correlates with cholinergic neuron loss and memory deficits. Therapeutic strategies aim to enhance NT-3 signaling to protect cholinergic [neurons](/entities/neurons) and improve synaptic function.
Parkinson's Disease
NT-3 provides neuroprotection to dopaminergic neurons in the substantia nigra. Studies show NT-3 can protect against MPTP-induced parkinsonism in animal models. Reduced NT-3 expression may contribute to dopaminergic neuron vulnerability.
Huntington's Disease
NT-3 signaling is impaired in HD, with reduced TrkC expression in the striatum. NT-3 delivery studies show protection of striatal neurons and improvement in behavioral deficits in mouse models.
Peripheral Neuropathy
NT-3 promotes peripheral nerve regeneration and sensory neuron survival. NT-3 gene therapy has shown promise in diabetic neuropathy and chemotherapy-induced peripheral neuropathy models.
Spinal Cord Injury
NT-3 promotes axonal regeneration and functional recovery after spinal cord injury. Combinatorial approaches with NT-3 and other neurotrophins show enhanced regeneration.
Expression Pattern
Central Nervous System
NT-3 is widely expressed in the developing and adult CNS:
- [Hippocampus](/brain-regions/hippocampus): Highest expression in dentate gyrus and CA3 region
- Cerebral cortex: Layer-specific expression in pyramidal neurons
- Basal forebrain: Cholinergic neuron targets
- Cerebellum: Purkinje cells and granule cells
- Spinal cord: Motor neurons and interneurons
Peripheral Nervous System
- Skeletal muscle (muscle spindles)
- Cardiac tissue
- Skin (dermal fibroblasts)
- Gastrointestinal tract
Therapeutic Implications
Gene Therapy Approaches
AAV-mediated NT-3 delivery to the brain or spinal cord has shown efficacy in animal models of AD, PD, and spinal cord injury. Clinical trials for peripheral neuropathy are underway.
Small Molecule Mimetics
Drug discovery efforts focus on developing small molecules that activate TrkC or enhance NT-3 signaling. These include TrkC agonists and BDNF/TrkC heterodimer mimetics.
Protein Delivery
Recombinant NT-3 protein delivery via intranasal or intravenous administration is being explored for CNS delivery. Challenges include short half-life and blood-brain barrier penetration.
Cell-Based Therapy
NTF3 gene-modified cells (mesenchymal stem cells, neural progenitor cells) provide sustained NT-3 release in target regions.
Animal Models
NTF3 Knockout Mice
NTF3⁻/⁻ mice die perinatally with severe sensory and autonomic deficits. Survivors show loss of proprioceptive neurons, hippocampal abnormalities, and motor coordination deficits.
Transgenic Overexpression
NT-3 transgenic mice show enhanced synaptic plasticity, improved memory, and increased hippocampal neuron survival. Used to study NT-3 therapeutic potential.
Viral Vector Models
AAV-NT3 and lentiviral-NT3 delivery in mouse models of AD, PD, and spinal cord injury demonstrates neuroprotection and functional improvement.
Research Directions
- [Blood-brain barrier](/entities/blood-brain-barrier) penetration strategies for NT-3 delivery
- TrkC-selective agonists to minimize off-target effects
- Combination therapies with other neurotrophic factors (BDNF, GDNF)
- Biomarker development for NT-3 therapeutic monitoring
- Clinical trials for peripheral neuropathy and spinal cord injury
Background
The study of Nt3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
Allen Brain Atlas Links
The Allen Brain Atlas provides comprehensive gene expression data across brain regions and cell types.
- [Allen Human Brain Atlas](https://human.brain-map.org/) — Gene expression data across the adult human brain
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — Gene expression in mouse brain
- [Allen Cell Type Atlas](https://celltype.brain-map.org/) — Single-cell transcriptomics data
- [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) — Developmental expression data
- [Allen Brain Map Portal](https://portal.brain-map.org/) — Access to all Allen Institute brain data
Gene-Specific Expression Data
Search for expression data on the Allen Brain Atlas:
- [Human Brain Atlas search for this gene](https://human.brain-map.org/microarray/search/show?search_term=NT3)
See Also
- [Neurotrophic Factor Signaling](/mechanisms/neurotrophic-factor-signaling)
- BDNF Gene
- NGF Gene
- TrkC Receptor
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Huntington's Disease](/diseases/huntingtons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Spinal Cord Injury](/diseases/spinal-cord-injury)
External Links
- [NCBI Gene - NTF3](https://www.ncbi.nlm.nih.gov/gene/4900)
- [UniProt - NTF3](https://www.uniprot.org/uniprot/P20783)
- [Ensembl - NTF3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000185652)
- [GeneCards - NTF3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTF3)
References
[Ernfors P, et al. (1994), Neurotrophin-3 is required for proper development of skin sensory neurons (1994)](https://pubmed.ncbi.nlm.nih.gov/7909099/)
[Maisonpierre PC, et al. (1990), NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression (1990)](https://pubmed.ncbi.nlm.nih.gov/2155254/)
[Tessarollo L, et al. (1994), NT-3, a neurotrophic factor for peripheral sensory and sympathetic neurons (1994)](https://pubmed.ncbi.nlm.nih.gov/7530388/)
[Lamballe F, et al. (1994), Diversity of Trk neurotrophin receptor functions (1994)](https://pubmed.ncbi.nlm.nih.gov/7531628/)
[Lyons WE, et al. (1999), Administration of NT-3 into the central nervous system of adult rats prevents axotomy-induced death of facial motor neurons (1999)](https://pubmed.ncbi.nlm.nih.gov/10398052/)
[Murer MG, et al. (2001), Chronic elevation of NT-3 by adenoviral gene transfer induces axonal sprouting and modifies motor function (2001)](https://pubmed.ncbi.nlm.nih.gov/11483252/)
[Zhang Y, et al. (2009), AAV-NT3 gene therapy enhances cognitive function in a rat model of Alzheimer's disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19219566/)
[Nagahara AH, et al. (2009), Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Parkinson's disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19198614/)Pathway Diagram
The following diagram shows the key molecular relationships involving NT3 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)